Prulacabtagene Leucel (Prula-cel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Prulacabtagene Leucel (Prula-cel), covering 2026-03-19 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease [Phase 1]